U.S. Insurance Stock News

The Morning Bull - US Market Morning Update Wednesday, Jan, 14 2026 US stock futures are slightly softer this morning, with E mini S&P 500 contracts off about 0.2%, as investors weigh cooler inflation against signs of steady demand. December CPI rose 0.3% month on month, with headline and core inflation both near 2.6% to 2.7%, which means the cost of living is rising but not running away. At the same time, new home sales sit at an annualized 737,000 and small business optimism is at 99.5,...

Unless you borrow money to invest, the potential losses are limited. But when you pick a company that is really...

Nebius Group (NasdaqGS:NBIS) is back in focus after agreeing to supply Microsoft with GPU infrastructure over five years. The contract is valued at up to US$19.4b, while the company prepares early deployment of NVIDIA’s Rubin platform. See our latest analysis for Nebius Group. The Microsoft agreement has arrived after a choppy period in which Nebius Group’s share price return fell 16.21% over three months. However, the 30-day share price return of 20.23% and 1-year total shareholder return of...

IES Holdings triggered article IES Holdings (IESC) has caught investor attention after recent share price moves, with the stock up 3% over the past week but showing a 6% decline over the past month. See our latest analysis for IES Holdings. The recent 1 day share price return of 2.96% and 7 day share price return of 4.83% come after a softer 30 day share price return of a 6.08% decline. At the same time, the 1 year total shareholder return of 78.41% and a very large 3 year total shareholder...

Beyond the headline price, you might be wondering whether AGCO at about US$111 per share still offers solid value or if most of the opportunity is already reflected in the stock. Over the short term, the stock has recorded returns of 1.2% over the past week, 1.8% over the last month, 5.0% year to date, and 15.5% over the past year. The 3 year return sits at a 13.2% decline and the 5 year return at 14.0%. Recent company news has focused on AGCO's positioning within the capital goods sector and...

TransDigm Group recently reported past quarterly results with revenue of US$2.44 billion, up 11.5% year on year, beating analyst estimates and delivering adjusted operating income and organic revenue ahead of expectations. Management also disclosed that a strong fourth-quarter finish pushed full-year fiscal 2025 revenue and EBITDA above the high end of prior guidance, highlighting operating momentum across the business. Against this backdrop of revenue and EBITDA outperforming guidance,...

Coda Octopus Group, Inc. ( NASDAQ:CODA ) shareholders would be excited to see that the share price has had a great...

We feel now is a pretty good time to analyse MDxHealth SA's ( NASDAQ:MDXH ) business as it appears the company may be...

Okta (OKTA) is back in focus after an analyst described the identity security provider as a contrarian value play, citing its valuation discount, expanding product set, and role in AI-driven security. See our latest analysis for Okta. The recent buyback authorization and upcoming conference appearance add extra context to Okta’s recent 7 day share price return of 4.11% and year to date share price return of 12.47%. The 1 year total shareholder return of 13.24% contrasts with a 5 year total...

SoFi Technologies, Inc. reported that longtime General Counsel Stephen Simcock retired effective December 31, 2025, and will remain with the company through December 31, 2026, under an advisor agreement to support the legal transition. His shift to an advisory role comes as SoFi is juggling mixed investor reactions to a large equity raise, regulatory headlines, and growing interest in its newer non-lending and blockchain-related offerings. Next, we will examine how Simcock’s advisory...

Recent commentary has highlighted Southern Copper Corp (NYSE: SCCO) as a quality candidate, citing its solid financial profile, profitable operations, high capital efficiency, and strong balance sheet as evidence of a resilient business. An interesting angle is that investors appear focused on the company’s top-tier resource portfolio and industry position as potential supports for long-term stability, even as its current valuation is described as high. With this backdrop of financial...

Key Insights Significantly high institutional ownership implies W&T Offshore's stock price is sensitive to their...

If you are wondering whether TJX Companies is still good value after a strong run, this article walks through what the current price really implies for the stock. TJX shares recently closed at US$158.14, with returns of 2.7% over 7 days, 1.3% over 30 days, 2.5% year to date, 34.3% over 1 year, 102.1% over 3 years and 153.5% over 5 years. This raises the question of how much of the story is already reflected in the price. Recent coverage has focused on TJX Companies as a major off price...

Unfortunately for some shareholders, the Exagen Inc. ( NASDAQ:XGN ) share price has dived 28% in the last thirty days...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Amphenol (APH) is back on investors’ radar after recent share price moves, with the stock closing at US$148.97 as the company’s broader return and growth profile draw closer scrutiny. See our latest analysis for Amphenol. Beyond the latest move to US$148.97, Amphenol’s 30 day share price return of 15.27% and 90 day share price return of 18.61% sit alongside a very large 5 year total shareholder return of roughly 4.7x. This points to momentum that has built over time rather than appearing...

If you are wondering whether Invesco’s current share price offers value or is starting to look stretched, you are in the right place for a clear, valuation focused checkup. Invesco’s stock most recently closed at US$28.30, with returns of 0.2% over 7 days, 7.8% over 30 days, 5.0% year to date, 78.2% over 1 year and 70.5% over 3 years. Many investors use these figures as a starting point for judging how sentiment and risk perception may be shifting. Recent attention on Invesco has focused on...

Amicus Therapeutics (FOLD) drew investor attention after recent trading left its shares around $14.32, and returns over the past month and past 3 months outpaced its year-to-date performance. See our latest analysis for Amicus Therapeutics. At a latest share price of $14.32, Amicus Therapeutics has seen its recent momentum build, with a 30 day share price return of 35.73% and a 90 day share price return of 71.09%. Its 1 year total shareholder return of 55.48% contrasts with a more modest 3...

Celanese (CE) has drawn fresh attention after board member Scott Sutton resigned following his appointment as Chief Executive Officer of Rayonier Advanced Materials, raising questions about board composition and future oversight. See our latest analysis for Celanese. While Sutton’s departure has sparked fresh discussion about governance, most of the recent attention on Celanese has centered on its share price. It trades at US$45.88 after a 90 day share price return of 14.16% and an 8.82% year...

If you are wondering whether Adams Diversified Equity Fund is still good value at around its recent price, this article walks through what the current data can and cannot tell you about that question. The fund's recent returns include a 0.3% decline over the last 7 days, a 3.6% gain over 30 days, 0.4% year to date, 25.8% over 1 year, 104.9% over 3 years, and 118.0% over 5 years, which may shape how investors are thinking about both opportunity and risk right now. Recent coverage around Adams...

IAC (IAC) has drawn investor interest after recent trading left the shares at US$40.20, with returns over the past month and past 3 months contrasting with a longer period of weaker total returns. See our latest analysis for IAC. The recent move to US$40.20 comes after a 4.1% 1 month share price return and a 20.8% 3 month share price return, while the 1 year total shareholder return of 17.2% contrasts with weaker 3 and 5 year total shareholder returns. This suggests momentum has picked up...

Investor interest in BrightSpring Health Services (BTSG) has picked up as favorable analyst sentiment focuses on its role in home and community-based care, highlighting the importance of its Pharmacy Solutions and Provider Services segments. See our latest analysis for BrightSpring Health Services. At a share price of $38.62, BrightSpring’s recent 30 day share price return of 5.69% builds on a 90 day share price return of 25.63%. The 1 year total shareholder return of 116.97% points to strong...

Monster Beverage (MNST) is back in focus after recent trading, with the stock last closing at $78.43. With solid reported revenue and profit figures, investors are reassessing how this beverage group fits into their portfolios. See our latest analysis for Monster Beverage. Recent trading has added to that interest, with a 1 day share price return of 1.20% and a 90 day share price return of 14.25%, while the 1 year total shareholder return of 56.55% points to stronger, longer term momentum. If...

If you are wondering whether ACADIA Pharmaceuticals' current share price still offers value after recent moves, this article walks through the numbers so you can judge for yourself. The stock closed at US$26.46, with a 1.8% decline over the last 7 days and a 2.5% decline over 30 days, while its 1 year return sits at 56.6% and its 3 year return at 46.6% against a 50.4% decline over 5 years. These mixed returns over different time frames help explain why some investors see renewed potential...